Test Bank For Lilley's Pharmacology for Canadian Health Care Practice 4th Edition by Kara Sealock, Cydnee Seneviratne 9780323694803 Chapter 1-58 Complete Guide.
4.1
ical Considerations 4. Patient-Focused Considerations 5. Gene Therapy and Pharmacogenomics 6. Medication Errors: Preventing and Responding 7. Patient Educat...
View example
Details
Comments
Reviews
ical Considerations 4. Patient-Focused Considerations 5. Gene Therapy and Pharmacogenomics 6. Medication Errors: Preventing and Responding 7. Patient Education and Drug Therapy 8. Over-the-Counter Drugs and Natural Health Products 9. Vitamins and Minerals 10. Principles of Drug Administration 11. Analgesic Drugs 12. General and Local Anaesthetics 13. Central Nervous System Depressants and Muscle Relaxants 14. Central Nervous System Stimulants and Related Drugs 15. Antiepileptic Drugs 16. Antiparkinsonian Drugs 17. Psychotherapeutic Drugs 18. Substance Misuse 19. Adrenergic Drugs 20. Adrenergic-Blocking Drugs 21. Cholinergic Drugs 22. Cholinergic-Blocking Drugs 23. Antihypertensive Drugs 24. Antianginal Drugs 25. Heart Failure Drugs 26. Antidysrhythmic Drugs 27. Coagulation Modifier Drugs 28. Antilipemic Drugs 29. Diuretic Drugs 30. Fluids and Electrolytes 31. Pituitary Drugs 32. Thyroid and Antithyroid Drugs 33. Antidiabetic Drugs 34. Adrenal Drugs 35. Women’s Health Drugs 36. Men’s Health Drugs∗ 37. Antihistamines, Decongestants, Antitussives, and Expectorants 38. Respiratory Drugs 39. Acid-Controlling Drugs 40. Antidiarrheal Drugs and Laxatives 41. Antiemetic and Antinausea Drugs 42. Nutritional Supplements 43. Antibiotics Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, and Tetracyclines 44. Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, and Other Drugs 45. Antiviral Drugs 46. Antitubercular Drugs 47. Antifungal Drugs 48. Antimalarial, Antiprotozoal, and Anthelmintic Drugs 49. Anti-inflammatory and Antigout Drugs 50. Immunosuppressant Drugs 51. Immunizing Drugs and Pandemic Preparedness 52. Antineoplastic Drugs Part 1: Cancer Overview and CellCycle–Specific Drugs 53. Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs 54. Biological Response–Modifying Drugs and Antirheumatic Drugs 55. Anemia Drugs 56. Dermatological Drugs 57. Ophthalmic Drugs 58. Otic Drugs
Specifications
Author Protutor
Published 30 Jul 2024
Included files PDF